Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seema Singhal

Showing results (91-100 of 140) with videos related to

Pageof 14
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center|July 3, 2026
Prevalence and Determinants of Female Sexual Dysfunction, and Its Association With Neurotrophic Biomarkers in Gynaecological Cancer Survivors: A Cross-Sectional StudyNilanchali Singh, Shalini Singh, Rizwana Quraishi, et al.
Haematologica|July 5, 2006
Bortezomib in combination with dexamethasone for the treatment of patients with relapsed and/or refractory multiple myeloma with less than optimal response to bortezomib aloneSundar Jagannath, Paul G Richardson, Bart Barlogie, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 1, 2021
A descriptive audit of healthcare workers exposed to COVID-19 at a tertiary care center in IndiaSadia Mansoor, K Aparna Sharma, Piyush Ranjan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 29, 2025
Multimodal Prehabilitation in Indian Women with Advanced Ovarian Cancer: Enhancing Nutritional, Psychological, and Surgical RecoverySaroj Rajan, Raj Kumar Yadav, Parmeet Kaur, et al.
Leukemia & Lymphoma|December 5, 2008
Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotypeBhawna Sirohi, Ray Powles, Seema Singhal, et al.
Blood|December 2, 2006
Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective studyAsher A Chanan-Khan, Jonathan L Kaufman, Jayesh Mehta, et al.
Journal of Perioperative Practice|September 21, 2024
Effect of preprocedure anxiety and oestrogen levels on Postoperative Nausea and Vomiting in patients undergoing diagnostic laparoscopy and hysteroscopy for infertility: A prospective observational pilot studyVishnu Narayanan Mr, Anjaleekrishna K, Puneet Khanna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2014
Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metforminSevim Dalva-Aydemir, Richa Bajpai, Maylyn Martinez, et al.
Blood|May 27, 2008
First thalidomide clinical trial in multiple myeloma: a decadeFrits van Rhee, Madhav Dhodapkar, John D Shaughnessy, et al.
Blood|July 16, 2005
Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myelomaPaul Gerard Guy Richardson, Bart Barlogie, James Berenson, et al.
Pageof 14

Showing results (91-100 of 140) with videos related to

Sort By:
Pageof 14
Cancer Control : Journal of the Moffitt Cancer Center|July 3, 2026
Prevalence and Determinants of Female Sexual Dysfunction, and Its Association With Neurotrophic Biomarkers in Gynaecological Cancer Survivors: A Cross-Sectional StudyNilanchali Singh, Shalini Singh, Rizwana Quraishi, et al.
Haematologica|July 5, 2006
Bortezomib in combination with dexamethasone for the treatment of patients with relapsed and/or refractory multiple myeloma with less than optimal response to bortezomib aloneSundar Jagannath, Paul G Richardson, Bart Barlogie, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 1, 2021
A descriptive audit of healthcare workers exposed to COVID-19 at a tertiary care center in IndiaSadia Mansoor, K Aparna Sharma, Piyush Ranjan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 29, 2025
Multimodal Prehabilitation in Indian Women with Advanced Ovarian Cancer: Enhancing Nutritional, Psychological, and Surgical RecoverySaroj Rajan, Raj Kumar Yadav, Parmeet Kaur, et al.
Leukemia & Lymphoma|December 5, 2008
Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotypeBhawna Sirohi, Ray Powles, Seema Singhal, et al.
Blood|December 2, 2006
Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective studyAsher A Chanan-Khan, Jonathan L Kaufman, Jayesh Mehta, et al.
Journal of Perioperative Practice|September 21, 2024
Effect of preprocedure anxiety and oestrogen levels on Postoperative Nausea and Vomiting in patients undergoing diagnostic laparoscopy and hysteroscopy for infertility: A prospective observational pilot studyVishnu Narayanan Mr, Anjaleekrishna K, Puneet Khanna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2014
Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metforminSevim Dalva-Aydemir, Richa Bajpai, Maylyn Martinez, et al.
Blood|May 27, 2008
First thalidomide clinical trial in multiple myeloma: a decadeFrits van Rhee, Madhav Dhodapkar, John D Shaughnessy, et al.
Blood|July 16, 2005
Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myelomaPaul Gerard Guy Richardson, Bart Barlogie, James Berenson, et al.
Pageof 14